Br J Community Nurs. 2009 Nov;14(11):474, 476, 478-80.

Lower urinary tract dysfunction in MS: management in the community.

Source

Department of Uro-Neurology, National Hospital for Neurology and Neurosurgery, London. j.panicker@ion.ucl.ac.uk

Abstract

Lower urinary tract dysfunction in multiple sclerosis is common and is highly amenable to treatment. Individuals may have bladder storage and/or voiding dysfunction. The risk of progression to renal failure is low and hence lower urinary tract dysfunction should be considered medically manageable in most individuals. Evaluation begins with history taking and is supplemented by using a bladder diary. Ultrasonography is used to assess the degree of incomplete bladder emptying, and for assessing upper urinary tract damage. Incomplete bladder emptying is most often managed by clean intermittent self-catheterization and should be initiated if post-void residual urine is greater than 100 mls. Storage symptoms are most often managed using antimuscarinic medications. Other options include desmopressin or detrusor muscle injection of botulinum toxin type A. There are specific situations where specialist urology services should be involved.

PMID:: 20166471; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Supplemental Content

Save items

Related citations in PubMed

Review Rehabilitation in practice: neurogenic lower urinary tract dysfunction and its management. [Clin Rehabil. 2010]
Review Rehabilitation in practice: neurogenic lower urinary tract dysfunction and its management.
Panicker JN, de Sèze M, Fowler CJ. Clin Rehabil. 2010 Jul; 24(7):579-89.
Review A UK consensus on the management of the bladder in multiple sclerosis. [J Neurol Neurosurg Psychiatry....]
Review A UK consensus on the management of the bladder in multiple sclerosis.
Fowler CJ, Panicker JN, Drake M, Harris C, Harrison SC, Kirby M, Lucas M, Macleod N, Mangnall J, North A, et al. J Neurol Neurosurg Psychiatry. 2009 May; 80(5):470-7.
Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra. [Urology. 2005]
Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra.
Smith CP, Nishiguchi J, O'Leary M, Yoshimura N, Chancellor MB. Urology. 2005 Jan; 65(1):37-41.
Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy. [J Urol. 2009]
Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy.
Giannantoni A, Rossi A, Mearini E, Del Zingaro M, Porena M, Berardelli A. J Urol. 2009 Oct; 182(4):1453-7. Epub 2009 Aug 15.
The effect of botulinum toxin type a on overactive bladder symptoms in patients with multiple sclerosis: a pilot study. [J Urol. 2010]
The effect of botulinum toxin type a on overactive bladder symptoms in patients with multiple sclerosis: a pilot study.
Mehnert U, Birzele J, Reuter K, Schurch B. J Urol. 2010 Sep; 184(3):1011-6.

See reviews... See all...

Cited by 1 PubMed Central article

Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice. [Ther Adv Neurol Disord. 2011]
Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice.
de Sa JC, Airas L, Bartholome E, Grigoriadis N, Mattle H, Oreja-Guevara C, O'Riordan J, Sellebjerg F, Stankoff B, Vass K, et al. Ther Adv Neurol Disord. 2011 May; 4(3):139-68.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Lower urinary tract dysfunction in MS: management in the community.
Lower urinary tract dysfunction in MS: management in the community.
Br J Community Nurs. 2009 Nov ;14(11):474, 476, 478-80.

PubMed
Microcircuitry related to the receptive field center of the on-beta ganglion cel...
Microcircuitry related to the receptive field center of the on-beta ganglion cell.
J Neurophysiol. 1991 Feb ;65(2):352-9.

PubMed
Clinical performance of vital bleaching techniques.
Clinical performance of vital bleaching techniques.
Oper Dent. 2010 Jan-Feb ;35(1):3-10.

PubMed
Hepatitis C virus infection in a Japanese leprosy sanatorium for the past 67 yea...
Hepatitis C virus infection in a Japanese leprosy sanatorium for the past 67 years.
J Med Virol. 2010 Apr ;82(4):556-61.

PubMed
Radial head replacement in capitellocondylar total elbow arthroplasty. 2- to 6-y...
Radial head replacement in capitellocondylar total elbow arthroplasty. 2- to 6-year follow-up evaluation in rheumatoid arthritis.
J Arthroplasty. 1991 Mar ;6(1):67-77.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Lower urinary tract dysfunction in MS: management in the community.

Source

Abstract

MeSH Terms, Substances

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Cited by 1 PubMed Central article

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information